Bliss GVS Pharma

{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "210.23",
    "chg": 3.04,
    "chgp": "1.47%",
    "dir": 1,
    "prev_price": "207.19",
    "mcapval": "2,245.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE416D01022",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "22.91 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3898639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BlissGVSPharmaL_mojoScore_3898639.png",
        "date": "2026-03-18 10:10:03",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-by-marketsmojo-3878002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BlissGVSPharmaL_mojoScore_3878002.png",
        "date": "2026-03-07 10:10:03",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the company’s current position as of 07 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3852863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_mojoScore_3852863.png",
        "date": "2026-02-24 10:10:04",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Bliss GVS Pharma Gains 2.50%: Key Price Milestones and Market Momentum in February",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-250-key-price-milestones-and-market-momentum-in-february-3849754",
        "imagepath": "",
        "date": "2026-02-21 15:04:38",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Stock opens at Rs.221.90 with a 1.88% gain</p>\n                    <p><strong>17 Feb:</strong> New 52-week high at Rs.244.05 and all-time high close at Rs.228.35</p>\n                    <p><strong>18 Feb:</strong> Minor correction with a 0.67% decline</p>\n                    <p><strong>19 Feb:</strong> Further dip amid Sensex decline, closing at Rs.226.60</p>\n                    <p><strong>20 Feb:</strong> Week closes at Rs.223.25, down 1.48% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.217.80</div></div>\n                  ..."
      },
      {
        "title": "Bliss GVS Pharma Ltd Hits New 52-Week High at Rs.244.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs24405-3844379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_priceRelatedfactors_3844379.png",
        "date": "2026-02-17 10:49:52",
        "description": "Bliss GVS Pharma Ltd has surged to a fresh 52-week high of Rs.244.05, marking a significant milestone in its stock performance. This new peak reflects robust momentum driven by sustained gains and strong market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bliss GVS Pharma Ltd Stock Hits All-Time High at Rs.228.35",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-at-rs22835-3844095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_priceRelatedfactors_3844095.png",
        "date": "2026-02-17 10:11:03",
        "description": "Bliss GVS Pharma Ltd has reached a new all-time high of Rs.228.35, underscoring a remarkable phase of growth and robust market performance within the Pharmaceuticals & Biotechnology sector. This milestone reflects the company’s sustained upward trajectory amid a challenging market environment."
      },
      {
        "title": "Bliss GVS Pharma Gains 18.69%: 5 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-1869-5-key-factors-driving-the-surge-3839801",
        "imagepath": "",
        "date": "2026-02-14 15:09:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Feb:</strong> New 52-week high of Rs.200</p>\n                    <p><strong>10 Feb:</strong> New 52-week high of Rs.211.8 and Q3 FY26 profit decline reported</p>\n                    <p><strong>11 Feb:</strong> New 52-week high of Rs.216.6</p>\n                    <p><strong>12 Feb:</strong> New 52-week high of Rs.217.1</p>\n                    <p><strong>13 Feb:</strong> Week closes at Rs.217.80 (-0.09%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.183.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><..."
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-3837229",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_mojoScore_3837229.png",
        "date": "2026-02-13 10:10:05",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 13 February 2026, providing investors with an up-to-date perspective on the company’s position in the market."
      },
      {
        "title": "Bliss GVS Pharma Ltd Hits New 52-Week High of Rs.217.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-of-rs2171-3834623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BlissGVSPharmaL_priceRelatedfactors_3834623.png",
        "date": "2026-02-12 09:53:50",
        "description": "Bliss GVS Pharma Ltd has surged to a fresh 52-week high of Rs.217.1, marking a significant milestone in its stock performance. This new peak reflects robust momentum as the pharmaceutical company continues to outperform its sector and broader market indices."
      }
    ],
    "total": 309,
    "sid": "730684",
    "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the second quarter and half year ended September 30, 2019 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshkati a Regional Daily, on November 13, 2019.",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, November 11, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019 published in The Economic Times an English Daily and Maharashtra Times a Regional Daily, on November 05, 2019.",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Updates",
      "datetime": "05-Nov-2019"
    },
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated October 07, 2019, titled \"we enclose herewith Press Release announcing that Kremoint Pharma Private Limited, India, a 70% subsidiary of Bliss GVS Pharma Limited (BGPL) has received a compliant certification from the U.S. Food and Drug Administration (FDA) that was based on the inspection conducted at the Company s facility located at M.I.D.C, Ambernath (East), Thane-District.\".",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Press Release",
      "datetime": "09-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bliss GVS Pharma Ltd is Rated Hold

2026-03-18 10:10:03

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold by MarketsMOJO

2026-03-07 10:10:03

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the company’s current position as of 07 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-02-24 10:10:04

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Bliss GVS Pharma Gains 2.50%: Key Price Milestones and Market Momentum in February

2026-02-21 15:04:38

Key Events This Week

16 Feb: Stock opens at Rs.221.90 with a 1.88% gain

17 Feb: New 52-week high at Rs.244.05 and all-time high close at Rs.228.35

18 Feb: Minor correction with a 0.67% decline

19 Feb: Further dip amid Sensex decline, closing at Rs.226.60

20 Feb: Week closes at Rs.223.25, down 1.48% on the day

Week Open

Rs.217.80

...

Read full news article

Bliss GVS Pharma Ltd Hits New 52-Week High at Rs.244.05

2026-02-17 10:49:52

Bliss GVS Pharma Ltd has surged to a fresh 52-week high of Rs.244.05, marking a significant milestone in its stock performance. This new peak reflects robust momentum driven by sustained gains and strong market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Bliss GVS Pharma Ltd Stock Hits All-Time High at Rs.228.35

2026-02-17 10:11:03

Bliss GVS Pharma Ltd has reached a new all-time high of Rs.228.35, underscoring a remarkable phase of growth and robust market performance within the Pharmaceuticals & Biotechnology sector. This milestone reflects the company’s sustained upward trajectory amid a challenging market environment.

Read full news article

Bliss GVS Pharma Gains 18.69%: 5 Key Factors Driving the Surge

2026-02-14 15:09:17

Key Events This Week

09 Feb: New 52-week high of Rs.200

10 Feb: New 52-week high of Rs.211.8 and Q3 FY26 profit decline reported

11 Feb: New 52-week high of Rs.216.6

12 Feb: New 52-week high of Rs.217.1

13 Feb: Week closes at Rs.217.80 (-0.09%)

Week Open

Rs.183.50

Week Close

<...

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-02-13 10:10:05

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 12 Nov 2025. While this rating change occurred several months ago, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 13 February 2026, providing investors with an up-to-date perspective on the company’s position in the market.

Read full news article

Bliss GVS Pharma Ltd Hits New 52-Week High of Rs.217.1

2026-02-12 09:53:50

Bliss GVS Pharma Ltd has surged to a fresh 52-week high of Rs.217.1, marking a significant milestone in its stock performance. This new peak reflects robust momentum as the pharmaceutical company continues to outperform its sector and broader market indices.

Read full news article

View All News